Evidence map›Paper›PMID 35101109›Full record

ArticleTrials2022

Integrated Sustainable childhood Pneumonia and Infectious disease Reduction in Nigeria (INSPIRING) through whole system strengthening in Jigawa, Nigeria: study protocol for a cluster randomised controlled trial.

Carina King, Rochelle Ann Burgess, Ayobami A Bakare, Funmilayo Shittu, Julius Salako, Damola Bakare, Obioma C Uchendu, Agnese Iuliano, Adamu Isah, Osebi Adams and 13 more

Abstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Carina KingDepartment of Global Public Health, Karolinska Institutet, Tomtebodavägen 18, 171 65, Stockholm, Sweden. carina.king@ki.se.ORCID http://orcid.org/0000-0002-6885-6716
Rochelle Ann BurgessInstitute for Global Health, University College London, London, UK.
Ayobami A BakareDepartment of Global Public Health, Karolinska Institutet, Tomtebodavägen 18, 171 65, Stockholm, Sweden.
Funmilayo ShittuDepartment of Paediatrics, University of Ibadan, Ibadan, Nigeria.
Julius SalakoDepartment of Paediatrics, University of Ibadan, Ibadan, Nigeria.
Damola BakareDepartment of Paediatrics, University of Ibadan, Ibadan, Nigeria.
Obioma C UchenduDepartment of Community Medicine, University College Hospital, Ibadan, Nigeria.
Agnese IulianoInstitute for Global Health, University College London, London, UK.
Adamu IsahSave the Children International, Abuja, Nigeria.
Osebi AdamsSave the Children International, Abuja, Nigeria.
Ibrahim HarunaSave the Children International, Abuja, Nigeria.
Abdullahi MagamaSave the Children International, Abuja, Nigeria.
Tahlil AhmedSave the Children UK, London, UK.
Samy AhmarSave the Children UK, London, UK.
Christine CassarSave the Children UK, London, UK.
Paula ValentineSave the Children UK, London, UK.
Temitayo Folorunso OlowookereGlaxoSmithKline (GSK), Lagos, Nigeria.
Matthew MacCallaGlaxoSmithKline (GSK), Brentford, UK.
Hamish R GrahamDepartment of Paediatrics, University College Hospital, Ibadan, Nigeria.
Eric D McCollumEudowood Division of Pediatric Respiratory Sciences, Department of Pediatrics, School of Medicine, Johns Hopkins University, Baltimore, USA.
Adegoke G FaladeDepartment of Paediatrics, University of Ibadan, Ibadan, Nigeria.
Tim ColbournInstitute for Global Health, University College London, London, UK.
INSPIRING Project Consortium

Funding

GSK-Save the Children Partnership 82603743
6 · The paper itself

Abstract

backgroundChild mortality remains unacceptably high, with Northern Nigeria reporting some of the highest rates globally (e.g. 192/1000 live births in Jigawa State). Coverage of key protect and prevent interventions, such as vaccination and clean cooking fuel use, is low. Additionally, knowledge, care-seeking and health system factors are poor. Therefore, a whole systems approach is needed for sustainable reductions in child mortality.

methodsThis is a cluster randomised controlled trial, with integrated process and economic evaluations, conducted from January 2021 to September 2022. The trial will be conducted in Kiyawa Local Government Area, Jigawa State, Nigeria, with an estimated population of 230,000. Clusters are defined as primary government health facility catchment areas (n = 33). The 33 clusters will be randomly allocated (1:1) in a public ceremony, and 32 clusters included in the impact evaluation. The trial will evaluate a locally adapted 'whole systems strengthening' package of three evidence-based methods: community men's and women's groups, Partnership Defined Quality Scorecard and healthcare worker training, mentorship and provision of basic essential equipment and commodities. The primary outcome is mortality of children aged 7 days to 59 months. Mortality will be recorded prospectively using a cohort design, and secondary outcomes measured through baseline and endline cross-sectional surveys. Assuming the following, we will have a minimum detectable effect size of 30%: (a) baseline mortality of 100 per 1000 livebirths, (b) 4480 compounds with 3 eligible children per compound, (c) 80% power, (d) 5% significance, (e) intra-cluster correlation of 0.007 and (f) coefficient of variance of cluster size of 0.74. Analysis will be by intention-to-treat, comparing intervention and control clusters, adjusting for compound and trial clustering. DISCUSSION: This study will provide robust evidence of the effectiveness and cost-effectiveness of community-based participatory learning and action, with integrated health system strengthening and accountability mechanisms, to reduce child mortality. The ethnographic process evaluation will allow for a rich understanding of how the intervention works in this context. However, we encountered a key challenge in calculating the sample size, given the lack of timely and reliable mortality data and the uncertain impacts of the COVID-19 pandemic.

trial registrationISRCTN 39213655 . Registered on 11 December 2019.

Indexed as

Child MortalityCommunity-Based Participatory ResearchInfant MortalityPneumoniaChild, PreschoolCross-Sectional StudiesFemaleHumansInfantInfant, NewbornMaleNigeriaPandemicsRandomized Controlled Trials as TopicSARS-CoV-2Child mortalityCluster randomised controlled trialCommunityNigeriaParticipatory learning and actionPneumonia

Identifiers

PMID35101109
PMCPMC8802253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.